InflaRx
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammator...
InflaRx Logo
About InflaRx
InflaRx N.V. operates as a clinical-stage biopharmaceutical company. The Company discovers and develops monoclonal antibodies drugs for the treatment of inflammatory diseases. InflaRx serves patients worldwide.
Address
Winzerlaer Str. 2,
Jena, 07745
Germany
Year founded
1970
Number of employees
0-100
Report inaccurate data
Request an update to help us keep the brand up-to-date.
